These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32671950)

  • 41. Risk and Cost Associated With Drug-Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France.
    Demessine L; Peyro-Saint-Paul L; Gardner EM; Ghosn J; Parienti JJ
    Open Forum Infect Dis; 2019 Mar; 6(3):ofz051. PubMed ID: 30949521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating the impact of antiretroviral and antiseizure medication interactions on treatment effectiveness among outpatient clinic attendees with HIV in Zambia.
    Navis A; Dallah I; Mabeta C; Musukuma K; Siddiqi OK; Bositis CM; Koralnik IJ; Gelbard HA; Theodore WH; Okulicz JF; Johnson BA; Sikazwe I; Bearden DR; Birbeck GL
    Epilepsia; 2020 Dec; 61(12):2705-2711. PubMed ID: 33084053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polypharmacy and Aging in People Living with HIV: 6 Years of Experience in a Multidisciplinary Outpatient Clinic.
    Cattaneo D; Oreni L; Meraviglia P; Minisci D; Astuti N; Antinori S; Gori A; Gervasoni C
    Drugs Aging; 2023 Jul; 40(7):665-674. PubMed ID: 37310576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study.
    Altunal LN; Yagcı Caglayık D; Ozel AS; Tukenmez Tigen E; Sili U; Erturk Sengel B; Aydın M; Korten V
    AIDS Patient Care STDS; 2023 Mar; 37(3):138-145. PubMed ID: 36812461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug-Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives.
    Cottura N; Kinvig H; Grañana-Castillo S; Wood A; Siccardi M
    J Clin Pharmacol; 2022 Jul; 62(7):835-846. PubMed ID: 34990024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compliance with clinical guidelines and adherence to antiretroviral therapy among patients living with HIV.
    Tandon N; Mao J; Shprecher A; Anderson AJ; Cao F; Jiao X; Brown K
    Curr Med Res Opin; 2019 Jan; 35(1):63-71. PubMed ID: 30173561
    [No Abstract]   [Full Text] [Related]  

  • 47. Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database.
    Patel N; Borg P; Haubrich R; McNicholl I
    Am J Health Syst Pharm; 2018 Aug; 75(15):1132-1139. PubMed ID: 29903710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical Review: What Dose of Rifabutin Is Recommended With Antiretroviral Therapy?
    Yapa HM; Boffito M; Pozniak A
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):138-52. PubMed ID: 26855245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of polypharmacy and pharmacotherapy complexity in elderly people living with HIV in Spain. POINT study.
    Gimeno-Gracia M; Sánchez-Rubio-Ferrández J; Robustillo-Cortés MLA; Morillo-Verdugo R
    Farm Hosp; 2020 Jul; 44(4):127-134. PubMed ID: 32646344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The challenge of HIV treatment in an era of polypharmacy.
    Back D; Marzolini C
    J Int AIDS Soc; 2020 Feb; 23(2):e25449. PubMed ID: 32011104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comorbidity Medications Are Dispensed to More People Receiving Antiretroviral Therapy for HIV Compared with the General Population in Australia.
    Dharan NJ; Radovich T; Che S; Petoumenos K; Juneja P; Law M; Huang R; McManus H; Polizzotto MN; Guy R; Cronin P; Cooper DA; Gray RT
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):291-296. PubMed ID: 31838857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polypharmacy and potential drug-drug interactions in an HIV-infected elderly population.
    Bastida C; Grau A; Márquez M; Tuset M; De Lazzari E; Martínez E; Gatell JM
    Farm Hosp; 2017 Sep; 41(5):618-624. PubMed ID: 28847251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction.
    Cota JM; Benavides TM; Fields JD; Jansen N; Ganesan A; Colombo RE; Blaylock JM; Maves RC; Agan BK; Okulicz JF
    PLoS One; 2021; 16(5):e0250607. PubMed ID: 33956843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.
    Molas E; Luque S; Retamero A; Echeverría-Esnal D; Guelar A; Montero M; Guerri R; Sorli L; Lerma E; Villar J; Knobel H
    HIV Clin Trials; 2018 Feb; 19(1):1-7. PubMed ID: 29179644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of Drug Interactions With Antiretroviral Medication in People With HIV.
    El Moussaoui M; Lambert I; Maes N; Sauvage AS; Frippiat F; Meuris C; Uurlings F; Lecomte M; Léonard P; Fombellida K; Vaira D; Vercheval C; Moutschen M; Darcis G
    Open Forum Infect Dis; 2020 Nov; 7(11):ofaa416. PubMed ID: 33204748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable.
    Seden K; Back D; Khoo S
    J Antimicrob Chemother; 2009 Jul; 64(1):5-8. PubMed ID: 19398457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of drug-drug interaction in an elderly human immunodeficiency virus population: Comparison of 3 expert databases.
    Ruellan AL; Bourneau-Martin D; Joyau C; Secher S; Fialaire P; Hitoto H; Leautez S; Michau C; Vatan R; Billaud E; Briet M; Jolliet P; Raffi F; Allavena C
    Br J Clin Pharmacol; 2021 Mar; 87(3):1194-1202. PubMed ID: 32696528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential or contraindicated drug-drug interactions with antiretroviral therapy in real-world settings in Taiwan.
    Wang CC; Li HJ; Shao CH; Sheng WH
    J Formos Med Assoc; 2022 Sep; 121(9):1714-1720. PubMed ID: 34961668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.